Luc Kestens - Publications

Affiliations: 
Universiteit Antwerpen (Belgium) 
Area:
Microbiology Biology

130 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Matavele Chissumba R, Magul C, Macamo R, Monteiro V, Enosse M, Macicame I, Cumbane V, Bhatt N, Viegas E, Imbach M, Eller LA, Polyak CS, Kestens L. Helios expressing regulatory T cells are correlated with decreased IL-2 producing CD8 T cells and antibody diversity in Mozambican individuals living chronically with HIV-1. Bmc Immunology. 23: 12. PMID 35287587 DOI: 10.1186/s12865-022-00487-3  0.37
2020 Goovaerts O, Massinga-Loembé M, Ondoa P, Ceulemans A, Worodria W, Mayanja-Kizza H, Colebunders R, Kestens L. Lack of elevated pre-ART elastase-ANCA levels in patients developing TB-IRIS. Plos One. 15: e0244800. PMID 33382831 DOI: 10.1371/journal.pone.0244800  0.34
2020 van Loon W, Gomez MP, Jobe D, Franken KLMC, Ottenhoff THM, Coninx M, Kestens L, Sutherland JS, Kampmann B, Tientcheu LD. Use of resuscitation promoting factors to screen for tuberculosis infection in household-exposed children in The Gambia. Bmc Infectious Diseases. 20: 469. PMID 32615981 DOI: 10.1186/S12879-020-05194-1  0.32
2019 Goovaerts O, Massinga-Loembé M, Ondoa P, Ceulemans A, Worodria W, Mayanja-Kizza H, Colebunders R, Kestens L. Increased KLRG1 and PD-1 expression on CD8 T lymphocytes in TB-IRIS. Plos One. 14: e0215991. PMID 31022273 DOI: 10.1371/Journal.Pone.0215991  0.349
2019 Ceulemans A, Bouzahzah C, Prat I, Urassa W, Kestens L. CD4-T cell enumeration in human immunodeficiency virus (HIV)-infected patients: A laboratory performance evaluation of Muse Auto CD4/CD4% system by World Health Organization prequalification of in vitro diagnostics. Plos One. 14: e0209677. PMID 30673713 DOI: 10.1371/journal.pone.0209677  0.389
2018 Adriaensen W, Abdellati S, van Henten S, Gedamu Y, Diro E, Vogt F, Mengesha B, Adem E, Kestens L, van Griensven J. Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients. Frontiers in Cellular and Infection Microbiology. 8: 428. PMID 30619775 DOI: 10.3389/fcimb.2018.00428  0.412
2017 Adriaensen W, Dorlo TPC, Vanham G, Kestens L, Kaye PM, van Griensven J. Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients. Frontiers in Immunology. 8: 1943. PMID 29375567 DOI: 10.3389/fimmu.2017.01943  0.337
2017 Matavele Chissumba R, Namalango E, Maphossa V, Macicame I, Bhatt N, Polyak C, Robb M, Michael N, Jani I, Kestens L. Helios + Regulatory T cell frequencies are correlated with control of viral replication and recovery of absolute CD4 T cells counts in early HIV-1 infection. Bmc Immunology. 18: 50. PMID 29246111 DOI: 10.1186/S12865-017-0235-7  0.488
2017 Natama HM, Ouedraogo DF, Sorgho H, Rovira-Vallbona E, Serra-Casas E, Somé MA, Coulibaly-Traoré M, Mens PF, Kestens L, Tinto H, Rosanas-Urgell A. Diagnosing congenital malaria in a high-transmission setting: clinical relevance and usefulness of P. falciparum HRP2-based testing. Scientific Reports. 7: 2080. PMID 28522856 DOI: 10.1038/S41598-017-02173-6  0.301
2017 Kenyon C, Osbak KK, Crucitti T, Kestens L. The immunological response to syphilis differs by HIV status; a prospective observational cohort study. Bmc Infectious Diseases. 17: 111. PMID 28143443 DOI: 10.1186/S12879-017-2201-7  0.445
2017 Daneau G, Aboud S, Prat I, Urassa W, Kestens L. Performance of FACSPresto Point-of-Care Instrument for CD4-T Cell Enumeration in Human Immunodeficiency Virus (HIV)-Infected Patients Attending Care and Treatment Clinics in Belgium and Tanzania. Plos One. 12: e0170248. PMID 28129324 DOI: 10.1371/Journal.Pone.0170248  0.494
2016 Hens J, Jennes W, Kestens L. The role of NK cells in HIV-1 protection: autologous, allogeneic or both? Aids Research and Therapy. 13: 15. PMID 27906005 DOI: 10.1186/s12981-016-0099-6  0.351
2016 Daneau G, Gous N, Scott L, Potgieter J, Kestens L, Stevens W. Human Immunodeficiency Virus (HIV)-Infected Patients Accept Finger Stick Blood Collection for Point-Of-Care CD4 Testing. Plos One. 11: e0161891. PMID 27556894 DOI: 10.1371/Journal.Pone.0161891  0.43
2016 Kestens L, Mandy F. Thirty-five years of CD4 T-cell counting in HIV infection: From flow cytometry in the lab to point-of-care testing in the field. Cytometry. Part B, Clinical Cytometry. 92: 437-444. PMID 27406947 DOI: 10.1002/Cyto.B.21400  0.503
2016 Dirix V, Schepers K, Massinga-Loembe M, Worodria W, Colebunders R, Singh M, Locht C, Kestens L, Mascart F. Added Value of Long-Term Cytokine Release Assays to Detect Mycobacterium tuberculosis Infection in HIV-Infected Subjects in Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). 72: 344-52. PMID 27306506 DOI: 10.1097/Qai.0000000000000980  0.467
2016 Hens J, Jennes W, Kestens L. The role of NK cells in HIV-1 protection: autologous, allogeneic or both? Aids Research and Therapy. 13: 15. PMID 26997965 DOI: 10.1186/S12981-016-0099-6  0.453
2016 Dirix V, Schepers K, Massinga-Loembe M, Worodria W, Colebunders R, Singh M, Locht C, Kestens L, Mascart F. Added value of long-term cytokine release assays to detect M. tuberculosis infection in HIV-infected subjects in Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26945178 DOI: 10.1097/QAI.0000000000000980  0.367
2016 Daneau G, Buyze J, Wade D, Diaw PA, Dieye TN, Thai S, Florence E, Lynen L, Kestens L. CD4 results with a bias larger than hundred cells per microliter can have a significant impact on the clinical decision during treatment initiation of HIV patients. Cytometry. Part B, Clinical Cytometry. PMID 26917223 DOI: 10.1002/Cyto.B.21366  0.391
2015 Scott LE, Campbell J, Westerman L, Kestens L, Vojnov L, Kohastsu L, Nkengasong J, Peter T, Stevens W. A meta-analysis of the performance of the Pima(TM) CD4 for point of care testing. Bmc Medicine. 13: 168. PMID 26208867 DOI: 10.1186/S12916-015-0396-2  0.395
2015 Goovaerts O, Jennes W, Massinga-Loembé M, Ondoa P, Ceulemans A, Vereecken C, Worodria W, Mayanja-Kizza H, Colebunders R, Kestens L. Lower Pre-Treatment T Cell Activation in Early- and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome. Plos One. 10: e0133924. PMID 26208109 DOI: 10.1371/Journal.Pone.0133924  0.368
2015 Wade D, Diaw PA, Daneau G, Diallo AA, Mboup S, Dieye TN, Kestens L. Laboratory and field evaluation of the Partec CyFlow miniPOC for absolute and relative CD4 T-cell enumeration. Plos One. 10: e0116663. PMID 25688553 DOI: 10.1371/Journal.Pone.0116663  0.432
2014 Wade D, Daneau G, Aboud S, Vercauteren GH, Urassa WS, Kestens L. WHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes (1999). 66: e98-107. PMID 24853304 DOI: 10.1097/Qai.0000000000000214  0.478
2014 Lejon V, Mumba Ngoyi D, Kestens L, Boel L, Barbé B, Kande Betu V, van Griensven J, Bottieau E, Muyembe Tamfum JJ, Jacobs J, Büscher P. Gambiense human african trypanosomiasis and immunological memory: effect on phenotypic lymphocyte profiles and humoral immunity. Plos Pathogens. 10: e1003947. PMID 24603894 DOI: 10.1371/Journal.Ppat.1003947  0.339
2014 Tran HT, Van den Bergh R, Vu TN, Laukens K, Worodria W, Loembé MM, Colebunders R, Kestens L, De Baetselier P, Raes G. The role of monocytes in the development of Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome. Immunobiology. 219: 37-44. PMID 23958034 DOI: 10.1016/J.Imbio.2013.07.004  0.357
2014 Padane A, Camara M, Seydi M, Jennes W, Diallo A, Fall M, Diaw P, Sow P, Mboup S, Kestens L, Dieye TN. Resistance to HIV-1 infection among HIV-exposed seronegative partners in HIV-discordant couples is associated with higher frequency of CD8+ T cells expressing CD107a and b molecules Bmc Infectious Diseases. 14. DOI: 10.1186/1471-2334-14-S2-P67  0.491
2013 Mbow M, Santos NSS, Camara M, Ba A, Niang A, Daneau G, Wade D, Diallo AA, Toupane M, Diakhaté M, Lèye N, Diaw PA, Mboup S, Kestens L, Dieye TN. HIV and Tuberculosis co-infection impacts T-cell activation markers but not the numbers subset of regulatory T-cells in HIV-1 infected patients. African Journal of Laboratory Medicine. 2: 76. PMID 29043167 DOI: 10.4102/Ajlm.V2I1.76  0.489
2013 Wade D, Diaw PA, Daneau G, Camara M, Dieye TN, Mboup S, Kestens L. CD4 T-cell enumeration in a field setting: evaluation of CyFlow counter using the CD4 easy count kit-dry and Pima CD4 systems. Plos One. 8: e75484. PMID 24066184 DOI: 10.1371/Journal.Pone.0075484  0.348
2013 Jennes W, Verheyden S, Mertens JW, Camara M, Seydi M, Dieye TN, Mboup S, Demanet C, Kestens L. Response: KIR/HLA incompatibility in HIV-1 transmission and importance of the 'missing self' model. Blood. 122: 1984-5. PMID 24030259 DOI: 10.1182/Blood-2013-06-502864  0.417
2013 Tran HT, Van den Bergh R, Loembé MM, Worodria W, Mayanja-Kizza H, Colebunders R, Mascart F, Stordeur P, Kestens L, De Baetselier P, Raes G. Modulation of the complement system in monocytes contributes to tuberculosis-associated immune reconstitution inflammatory syndrome. Aids (London, England). 27: 1725-34. PMID 23807270 DOI: 10.1097/Qad.0B013E328361648B  0.417
2013 Kirenga BJ, Worodria W, Massinga-Loembe M, Nalwoga T, Manabe YC, Kestens L, Colebunders R, Mayanja-Kizza H. Tuberculin skin test conversion among HIV patients on antiretroviral therapy in Uganda. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 17: 336-41. PMID 23407223 DOI: 10.5588/Ijtld.12.0298  0.507
2013 Jennes W, Verheyden S, Mertens JW, Camara M, Seydi M, Dieye TN, Mboup S, Demanet C, Kestens L. Inhibitory KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission. Blood. 121: 1157-64. PMID 23243280 DOI: 10.1182/Blood-2012-09-455352  0.443
2013 Affolabi D, Odoun M, Martin A, Koukpemedji L, Palomino JC, Kestens L, Anagonou S, Portaels F. Rapid low-cost identification of Mycobacterium tuberculosis complex using p-nitro-benzoic acid (PNB) as inhibitor and the resazurin microplate assay (REMA): A preliminary study African Journal of Microbiology Research. 7: 3135-3138. DOI: 10.5897/Ajmr10.278  0.602
2013 Kestens L. Monitoring HIV Patients with CD4 Point-of-Care (POC) Instruments: Are Those Technologies Good Enough? Journal of Tropical Diseases. 1. DOI: 10.4172/2329-891X.1000E102  0.489
2012 Camara M, Seydi M, Dieye TN, Sow PS, Mboup S, Kestens L, Jennes W. Association between herpes simplex virus type 2 and HIV-1 in a population of married couples from Dakar, Senegal International Journal of Std and Aids. 23: 810-814. PMID 23155102 DOI: 10.1258/Ijsa.2012.011436  0.447
2012 Jennes W, Kyongo JK, Vanhommerig E, Camara M, Coppens S, Seydi M, Mboup S, Heyndrickx L, Kestens L. Molecular epidemiology of HIV-1 transmission in a cohort of HIV-1 concordant heterosexual couples from Dakar, Senegal. Plos One. 7: e37402. PMID 22615999 DOI: 10.1371/Journal.Pone.0037402  0.449
2012 Worodria W, Menten J, Massinga-Loembe M, Mazakpwe D, Bagenda D, Koole O, Mayanja-Kizza H, Kestens L, Mugerwa R, Reiss P, Colebunders R. Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection. Antiviral Therapy. 17: 841-8. PMID 22543224 DOI: 10.3851/Imp2108  0.429
2012 Mous K, Jennes W, Camara M, Seydi M, Daneau G, Mboup S, Kestens L, Van Ostade X. Expression analysis of LEDGF/p75, APOBEC3G, TRIM5alpha, and tetherin in a Senegalese cohort of HIV-1-exposed seronegative individuals. Plos One. 7: e33934. PMID 22479480 DOI: 10.1371/Journal.Pone.0033934  0.486
2012 Diallo AA, Niang A, Daneau G, Badiane JK, Camara M, Hane AA, Kestens L, Mboup S, Dieye T. Evaluation of the accuracy of primary CD4 gating in Senegalese individuals coinfected with HIV and tuberculosis Retrovirology. 9. DOI: 10.1186/1742-4690-9-S1-P18  0.457
2011 Conesa-Botella A, Loembé MM, Manabe YC, Worodria W, Mazakpwe D, Luzinda K, Mayanja-Kizza H, Miri M, Mbabazi O, Koole O, Kestens L, Colebunders R. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome. Journal of Acquired Immune Deficiency Syndromes (1999). 58: 463-8. PMID 21963941 DOI: 10.1097/Qai.0B013E31823801De  0.479
2011 Diaw PA, Daneau G, Coly AA, Ndiaye BP, Wade D, Camara M, Mboup S, Kestens L, Dieye TN. Multisite evaluation of a point-of-care instrument for CD4(+) T-cell enumeration using venous and finger-prick blood: the PIMA CD4. Journal of Acquired Immune Deficiency Syndromes (1999). 58: e103-11. PMID 21909029 DOI: 10.1097/Qai.0B013E318235B378  0.449
2011 Dieye TN, Diaw PA, Daneau G, Wade D, Sylla Niang M, Camara M, Diallo AA, Toure Kane C, Diop Ndiaye H, Mbengue B, Dieye A, Kestens L, Mboup S. Evaluation of a flow cytometry method for CD4 T cell enumeration based on volumetric primary CD4 gating using thermoresistant reagents. Journal of Immunological Methods. 372: 7-13. PMID 21835181 DOI: 10.1016/J.Jim.2011.07.012  0.467
2011 Mous K, Jennes W, De Roo A, Pintelon I, Kestens L, Van Ostade X. Intracellular detection of differential APOBEC3G, TRIM5alpha, and LEDGF/p75 protein expression in peripheral blood by flow cytometry. Journal of Immunological Methods. 372: 52-64. PMID 21784078 DOI: 10.1016/J.Jim.2011.06.028  0.421
2011 Worodria W, Massinga-Loembe M, Mazakpwe D, Luzinda K, Menten J, Van Leth F, Mayanja-Kizza H, Kestens L, Mugerwa RD, Reiss P, Colebunders R. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 58: 32-7. PMID 21654499 DOI: 10.1097/Qai.0B013E3182255Dc2  0.46
2011 Jennes W, Verheyden S, Demanet C, Menten J, Vuylsteke B, Nkengasong JN, Kestens L. Low CD4+ T cell counts among African HIV-1 infected subjects with group B KIR haplotypes in the absence of specific inhibitory KIR ligands. Plos One. 6: e17043. PMID 21347267 DOI: 10.1371/Journal.Pone.0017043  0.459
2011 Worodria W, Massinga-Loembe M, Mayanja-Kizza H, Namaganda J, Kambugu A, Manabe YC, Kestens L, Colebunders R. Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART. Clinical & Developmental Immunology. 2011: 758350. PMID 21197091 DOI: 10.1155/2011/758350  0.414
2010 Sopoh GE, Dossou AD, Brun LV, Barogui YT, Houézo JG, Affolabi D, Anagonou SY, Johnson RC, Kestens L, Portaels F. Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms. The American Journal of Tropical Medicine and Hygiene. 83: 307-13. PMID 20682873 DOI: 10.4269/Ajtmh.2010.09-0617  0.647
2010 Camara M, Dieye TN, Seydi M, Diallo AA, Fall M, Diaw PA, Sow PS, Mboup S, Kestens L, Jennes W. Low-level CD4+ T cell activation in HIV-exposed seronegative subjects: influence of gender and condom use. The Journal of Infectious Diseases. 201: 835-42. PMID 20136413 DOI: 10.1086/651000  0.476
2009 Affolabi D, Faïhun F, Sanoussi N, Anyo G, Shamputa IC, Rigouts L, Kestens L, Anagonou S, Portaels F. Possible outbreak of streptomycin-resistant Mycobacterium tuberculosis Beijing in Benin. Emerging Infectious Diseases. 15: 1123-5. PMID 19624936 DOI: 10.3201/Eid1507.080697  0.606
2009 Conesa-Botella A, Mathieu C, Colebunders R, Moreno-Reyes R, van Etten E, Lynen L, Kestens L. Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome? Aids Research and Therapy. 6: 4. PMID 19383117 DOI: 10.1186/1742-6405-6-4  0.325
2009 Affolabi D, Anyo G, Faïhun F, Sanoussi N, Shamputa IC, Rigouts L, Kestens L, Anagonou S, Portaels F. First molecular epidemiological study of tuberculosis in Benin. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 13: 317-22. PMID 19275790  0.564
2009 Ondoa P, Vereecken C, Asahchop EL, Litzroth A, Diallo A, Fransen K, Dieye T, Ryder R, Mboup S, Kestens L. Proof of principle: an HIV p24 microsphere immunoassay with potential application to HIV clinical diagnosis. Cytometry. Part B, Clinical Cytometry. 76: 231-6. PMID 19012321 DOI: 10.1002/Cyto.B.20466  0.446
2009 Mous K, Jennes W, Kestens L, Van Ostade X. P10-08. Intracellular detection of differential APOBEC3G, TRIM5a, and LEDGF/p75 expression in peripheral blood from HIV-1 infected subjects by flow cytometry Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P139  0.425
2008 Affolabi D, Odoun M, Sanoussi N, Martin A, Palomino JC, Kestens L, Anagonou S, Portaels F. Rapid and inexpensive detection of multidrug-resistant Mycobacterium tuberculosis with the nitrate reductase assay using liquid medium and direct application to sputum samples. Journal of Clinical Microbiology. 46: 3243-5. PMID 18753346 DOI: 10.1128/Jcm.00083-08  0.599
2008 Affolabi D, Sanoussi N, Odoun M, Martin A, Koukpemedji L, Palomino JC, Kestens L, Anagonou S, Portaels F. Rapid detection of multidrug-resistant Mycobacterium tuberculosis in Cotonou (Benin) using two low-cost colorimetric methods: resazurin and nitrate reductase assays. Journal of Medical Microbiology. 57: 1024-7. PMID 18628506 DOI: 10.1099/Jmm.0.2008/000406-0  0.603
2008 Jennes W, Camara M, Dièye T, Mboup S, Kestens L. Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection. Journal of Virology. 82: 8619-28. PMID 18562522 DOI: 10.1128/Jvi.00027-08  0.494
2008 Affolabi D, Odoun M, Sanoussi CN, Tanimomo-Kledjo B, Saïzonou D, Soumaïla K, Kestens L, Anagonou SY, Portaels F. Bulk staining of smears: no demonstrated risk of bacilli transfer from a positive to a negative smear. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 12: 683-5. PMID 18492337  0.542
2008 Beels D, Heyndrickx L, Vereecken K, Vermoesen T, Michiels L, Vanham G, Kestens L. Production of human immunodeficiency virus type 1 (HIV-1) pseudoviruses using linear HIV-1 envelope expression cassettes. Journal of Virological Methods. 147: 99-107. PMID 17904649 DOI: 10.1016/J.Jviromet.2007.08.014  0.43
2007 Huyst V, Lynen L, Bottieau E, Zolfo M, Kestens L, Colebunders R. Immune reconstitution inflammatory syndrome in an HIV/TB co-infected patient four years after starting antiretroviral therapy Acta Clinica Belgica. 62: 126-129. PMID 17547295 DOI: 10.1179/Acb.2007.022  0.48
2006 Jennes W, Verheyden S, Demanet C, Adjé-Touré CA, Vuylsteke B, Nkengasong JN, Kestens L. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. Journal of Immunology (Baltimore, Md. : 1950). 177: 6588-92. PMID 17082569 DOI: 10.4049/Jimmunol.177.10.6588  0.397
2006 Van Geertruyden JP, Mulenga M, Kasongo W, Polman K, Colebunders R, Kestens L, D'Alessandro U. CD4 T-cell count and HIV-1 infection in adults with uncomplicated malaria. Journal of Acquired Immune Deficiency Syndromes (1999). 43: 363-7. PMID 17079994 DOI: 10.1097/01.Qai.0000243125.98024.Da  0.503
2006 Van Geertruyden JP, Mulenga M, Mwananyanda L, Chalwe V, Moerman F, Chilengi R, Kasongo W, Van Overmeir C, Dujardin JC, Colebunders R, Kestens L, D'Alessandro U. HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria. The Journal of Infectious Diseases. 194: 917-25. PMID 16960779 DOI: 10.1086/507310  0.462
2006 Lynen L, Teav S, Vereecken C, Munter PD, An S, Jacques G, Kestens L. Validation of primary CD4 gating as an affordable strategy for absolute CD4 counting in Cambodia Journal of Acquired Immune Deficiency Syndromes. 43: 179-185. PMID 16940854 DOI: 10.1097/01.Qai.0000242447.82403.C2  0.371
2006 Heeney JL, Rutjens E, Verschoor EJ, Niphuis H, ten Haaft P, Rouse S, McClure H, Balla-Jhagjhoorsingh S, Bogers W, Salas M, Cobb K, Kestens L, Davis D, van der Groen G, Courgnaud V, et al. Transmission of simian immunodeficiency virus SIVcpz and the evolution of infection in the presence and absence of concurrent human immunodeficiency virus type 1 infection in chimpanzees. Journal of Virology. 80: 7208-18. PMID 16809326 DOI: 10.1128/Jvi.00382-06  0.438
2006 Lynen L, Thai S, De Munter P, Leang B, Sokkab A, Schrooten W, Huyst V, Kestens L, Jacques G, Colebunders R, Menten J, Van Den Ende J. The added value of a CD4 count to identify patients eligible for highly active antiretroviral therapy among HIV-positive adults in Cambodia Journal of Acquired Immune Deficiency Syndromes. 42: 322-324. PMID 16688095 DOI: 10.1097/01.Qai.0000221682.37316.D5  0.436
2006 Ondoa P, Dieye TN, Vereecken C, Camara M, Diallo AA, Fransen K, Litzroth A, Mboup S, Kestens L. Evaluation of HIV-1 p24 antigenemia and level of CD8+CD38+ T cells as surrogate markers of HIV-1 RNA viral load in HIV-1-infected patients in Dakar, Senegal. Journal of Acquired Immune Deficiency Syndromes (1999). 41: 416-24. PMID 16652048 DOI: 10.1097/01.Qai.0000209901.12750.D0  0.484
2006 Tavernier A, Jennes W, Fransen K, De Roo A, Kestens L. Dominant ex vivo cross-stimulation of CD8+ T-cells with whole soluble gag protein in HIV-infected subjects. Journal of Acquired Immune Deficiency Syndromes (1999). 41: 548-56. PMID 16652028 DOI: 10.1097/01.Qai.0000209908.20373.72  0.48
2006 Jennes W, Evertse D, Borget MY, Vuylsteke B, Maurice C, Nkengasong JN, Kestens L. Suppressed cellular alloimmune responses in HIV-exposed seronegative female sex workers Clinical and Experimental Immunology. 143: 435-444. PMID 16487242 DOI: 10.1111/J.1365-2249.2006.03017.X  0.449
2005 Ariën KK, Abraha A, Quiñones-Mateu ME, Kestens L, Vanham G, Arts EJ. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. Journal of Virology. 79: 8979-90. PMID 15994792 DOI: 10.1128/Jvi.79.14.8979-8990.2005  0.431
2005 Njai HF, Lewi PJ, Janssen CG, Garcia S, Fransen K, Kestens L, Vanham G, Janssen PA. Pre-incubation of cell-free HIV-1 group M isolates with non-nucleoside reverse transcriptase inhibitors blocks subsequent viral replication in co-cultures of dendritic cells and T cells. Antiviral Therapy. 10: 255-62. PMID 15865220  0.335
2005 Dieye TN, Vereecken C, Diallo AA, Ondoa P, Diaw PA, Camara M, Karam F, Mboup S, Kestens L. Absolute CD4 T-cell counting in resource-poor settings: direct volumetric measurements versus bead-based clinical flow cytometry instruments. Journal of Acquired Immune Deficiency Syndromes (1999). 39: 32-7. PMID 15851911 DOI: 10.1097/01.Qai.0000160515.20581.Ad  0.41
2005 Ondoa P, Koblavi-Dème S, Borget MY, Nolan ML, Nkengasong JN, Kestens L. Assessment of CD8+ T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Côte d'Ivoire Clinical and Experimental Immunology. 140: 138-148. PMID 15762885 DOI: 10.1111/J.1365-2249.2005.02734.X  0.505
2004 Jennes W, Vereecken C, Fransen K, de Roo A, Kestens L. Disturbed secretory capacity for macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta in progressive HIV infection. Aids Research and Human Retroviruses. 20: 1087-91. PMID 15585099 DOI: 10.1089/Aid.2004.20.1087  0.389
2004 Van Herrewege Y, Vanham G, Michiels J, Fransen K, Kestens L, Andries K, Janssen P, Lewi P. A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides. Antimicrobial Agents and Chemotherapy. 48: 3684-9. PMID 15388420 DOI: 10.1128/Aac.48.10.3684-3689.2004  0.419
2004 Florence E, Dreezen C, Schrooten W, Van Esbroeck M, Kestens L, Fransen K, De Roo A, Colebunders R. The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment. International Journal of Std & Aids. 15: 538-42. PMID 15307965 DOI: 10.1258/0956462041558159  0.447
2004 Schrooten W, Florence E, Dreezen C, Van Esbroeck M, Fransen K, Alonso A, Desmet P, Colebunders R, Kestens L, De Roo A. Five-year immunological outcome of highly active antiretroviral treatment in a clinical setting: results from a single HIV treatment centre. International Journal of Std & Aids. 15: 523-8. PMID 15307962 DOI: 10.1258/0956462041558267  0.452
2004 Scott JT, Johnson RC, Aguiar J, Debacker M, Kestens L, Guedenon A, Gryseels B, Portaels F. Schistosoma haematobium infection and Buruli ulcer. Emerging Infectious Diseases. 10: 551-2. PMID 15116714 DOI: 10.3201/Eid1003.020514  0.328
2004 Koblavi-Dème S, Kestens L, Hanson D, Otten RA, Borget MY, Bilé C, Wiktor SZ, Roels TH, Chorba T, Nkengasong JN. Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Côte D'Ivoire. Aids (London, England). 18: 413-9. PMID 15090792 DOI: 10.1097/00002030-200402200-00006  0.502
2004 Jennes W, Vuylsteke B, Borget MY, Traore-Ettiegne V, Maurice C, Nolan M, Nkengasong JN, Kestens L. HIV-specific T helper responses and frequency of exposure among HIV-exposed seronegative female sex workers in Abidjan, Cote d'Ivoire. The Journal of Infectious Diseases. 189: 602-10. PMID 14767812 DOI: 10.1086/381454  0.442
2004 Van Herrewege Y, Michiels J, Van Roey J, Fransen K, Kestens L, Balzarini J, Lewi P, Vanham G, Janssen P. In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides. Antimicrobial Agents and Chemotherapy. 48: 337-9. PMID 14693562 DOI: 10.1128/Aac.48.1.337-339.2004  0.431
2003 Koblavi-Dème S, Maran M, Kabran N, Borget MY, Kalou M, Kestens L, Maurice C, Sassan-Morokro M, Ekpini ER, Roels TH, Chorba T, Nkengasong JN. Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy. Aids (London, England). 17: S17-22. PMID 14565605 DOI: 10.1097/00002030-200317003-00003  0.431
2003 Van Blerk M, Bernier M, Bossuyt X, Chatelain B, D'Hautcourt JL, Demanet C, Kestens L, Van Bockstaele D, Crucitti T, Libeer JC. National external quality assessment scheme for lymphocyte immunophenotyping in Belgium. Clinical Chemistry and Laboratory Medicine. 41: 323-30. PMID 12705342 DOI: 10.1515/Cclm.2003.052  0.35
2003 Jennes W, Sawadogo S, Koblavi-Dème S, Vuylsteke B, Maurice C, Roels TH, Chorba T, Nkengasong JN, Kestens L. Cellular human immunodeficiency virus (HIV)-protective factors: a comparison of HIV-exposed seronegative female sex workers and female blood donors in Abidjan, Côte d'Ivoire. The Journal of Infectious Diseases. 187: 206-14. PMID 12552445 DOI: 10.1086/346049  0.46
2003 Ondoa P, Vereecken C, Fransen K, Colebunders R, van der Groen G, Heeney JL, Kestens L. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans. Journal of Medical Virology. 69: 297-305. PMID 12526038 DOI: 10.1002/Jmv.10289  0.454
2002 Van Herrewege Y, Penne L, Vereecken C, Fransen K, van der Groen G, Kestens L, Balzarini J, Vanham G. Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission. Aids Research and Human Retroviruses. 18: 1091-102. PMID 12396448 DOI: 10.1089/088922202320567833  0.466
2002 Jennes W, Kestens L, Nixon DF, Shacklett BL. Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15--the Amplispot assay. Journal of Immunological Methods. 270: 99-108. PMID 12379342 DOI: 10.1016/S0022-1759(02)00275-2  0.348
2002 Johnson RC, Ifebe D, Hans-Moevi A, Kestens L, Houessou R, Guédénon A, Meyers WM, Portaels F. Disseminated Mycobacterium ulcerans disease in an HIV-positive patient: a case study. Aids (London, England). 16: 1704-5. PMID 12172103 DOI: 10.1097/00002030-200208160-00027  0.426
2002 Ondoa P, Davis D, Kestens L, Vereecken C, Garcìa Ribas S, Fransen K, Heeney J, van der Groen G. In vitro susceptibility to infection with SIVcpz and HIV-1 is lower in chimpanzee than in human peripheral blood mononuclear cells. Journal of Medical Virology. 67: 301-11. PMID 12116019 DOI: 10.1002/Jmv.10078  0.492
2002 Ondoa P, Vingerhoets J, Vereecken C, van der Groen G, Heeney JL, Kestens L. In vitro replication of SIVcpz is suppressed by beta-chemokines and CD8+ T cells but not by natural killer cells of infected chimpanzees. Aids Research and Human Retroviruses. 18: 373-82. PMID 11897039 DOI: 10.1089/088922202753519151  0.417
2002 Jennes W, Sawadogo S, Koblavi-Dème S, Vuylsteke B, Maurice C, Roels TH, Chorba T, Nkengasong JN, Kestens L. Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire. Aids Research and Human Retroviruses. 18: 171-7. PMID 11839151 DOI: 10.1089/08892220252781220  0.464
2001 Ondoa P, Kestens L, Davis D, Vereecken C, Willems B, Fransen K, Vingerhoets J, Zissis G, Haaft PT, Heeney J, Van Groen GD. Longitudinal comparison of virus load parameters and CD8 T-cell suppressive capacity in two SIVcpz-infected chimpanzees Journal of Medical Primatology. 30: 243-253. PMID 11990239 DOI: 10.1034/J.1600-0684.2001.D01-56.X  0.323
2001 Ondoa P, Davis D, Willems B, Heyndrickx L, Kestens L, Van Berg ID, Coppens S, Janssens W, Heeney J, Van Groen GD. Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally Journal of Medical Virology. 65: 765-776. PMID 11745943 DOI: 10.1002/Jmv.2102  0.313
2001 Adjé CA, Bilé CE, Kestens L, Koblavi-Deme S, Ghys PD, Maurice C, Kalou-Badirou M, Kabran N, Ekpini RE, Roels TH, Wiktor SZ, Nkengasong JN. Lack of effect of chemokine receptor CCR2b gene polymorphism (64I) on HIV-1 plasma RNA viral load and immune activation among HIV-1 seropositive female workers in Abidjan, Côte d'Ivoire. Journal of Medical Virology. 64: 398-401. PMID 11468722 DOI: 10.1002/Jmv.1064  0.452
2001 Nkengasong JN, Kestens L, Ghys PD, Koblavi-Dème S, Bilé C, Kalou M, Ya LK, Traoré-Ettiègne V, Maurice C, Laga M, Wiktor SZ, Greenberg AE. Human immunodeficiency virus type 1 (HIV-1) plasma virus load and markers of immune activation among HIV-infected female sex workers with sexually transmitted diseases in Abidjan, Côte d'Ivoire Journal of Infectious Diseases. 183: 1405-1408. PMID 11294674 DOI: 10.1086/319855  0.477
2001 Vanham G, Davis D, Willems B, Penne L, Kestens L, Janssens W, van der Groen G. Dendritic cells, exposed to primary, mixed phenotype HIV-1 isolates preferentially, but not exclusively, replicate CCR5-using clones. Aids (London, England). 14: 1874-6. PMID 10985336 DOI: 10.1097/00002030-200008180-00034  0.424
2000 Vanham G, Penne L, Allemeersch H, Kestens L, Willems B, van der Groen G, Jeang KT, Toossi Z, Rich E. Modeling HIV transfer between dendritic cells and T cells: importance of HIV phenotype, dendritic cell-T cell contact and T-cell activation. Aids (London, England). 14: 2299-311. PMID 11089618 DOI: 10.1097/00002030-200010200-00011  0.475
2000 de Baar MP, Janssens W, de Ronde A, Fransen K, Colebunders R, Kestens L, van der Groen G, Goudsmit J. Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo. Aids Research and Human Retroviruses. 16: 1385-94. PMID 11018858 DOI: 10.1089/08892220050140937  0.363
2000 Nkengasong JN, Kestens L, Ghys PD, Koblavi-Deme S, Otten RA, Bile C, Maurice C, Kalou M, Laga M, Wiktor SZ, Greenberg AE. Dual infection with human immunodeficiency virus type 1 and type 2: Impact on HIV type 1 viral load and immune activation markers in HIV-seropositive female sex workers in Abidjan, Ivory Coast Aids Research and Human Retroviruses. 16: 1371-1378. PMID 11018856 DOI: 10.1089/08892220050140919  0.49
2000 Vanham G, van Tendeloo V, Willems B, Penne L, Kestens L, Beirnaert E, Fransen K, Heyndrickx L, Zhong P, Davis D, Berneman Z, van Der Groen G, Van Bockstaele D. The HIV-2 genotype and the HIV-1 syncytium-inducing phenotype are associated with a lower virus replication in dendritic cells. Journal of Medical Virology. 60: 300-12. PMID 10630963 DOI: 10.1002/(Sici)1096-9071(200003)60:3<300::Aid-Jmv9>3.0.Co;2-G  0.475
1999 Vanham G, Penne L, Devalck J, Kestens L, Colebunders R, Bosmans E, Thielemans K, Ceuppens JL. Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection. Clinical and Experimental Immunology. 117: 335-42. PMID 10444266 DOI: 10.1046/J.1365-2249.1999.00987.X  0.45
1998 Bogaerts J, Kestens L, Van Dyck E, Tello WM, Akingeneye J, Mukantabana V. Genital ulcers in a primary health clinic in Rwanda: Impact of HIV infection on diagnosis and ulcer healing (1986-1992) International Journal of Std and Aids. 9: 706-710. PMID 9863586 DOI: 10.1258/0956462981921242  0.441
1998 Vingerhoets J, Bisalinkumi E, Penne G, Colebunders R, Bosmans E, Kestens L, Vanham G. Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection Immunology Letters. 61: 53-61. PMID 9562375 DOI: 10.1016/S0165-2478(97)00162-4  0.381
1998 Vingerhoets J, Dohlsten M, Penne G, Colebunders R, Sansom D, Bosmans E, Kestens L, Vanham G. Superantigen activation of CD4+ and CD8+ T cells from HIV-infected subjects: Role of costimulatory molecules and antigen-presenting cells (APC) Clinical and Experimental Immunology. 111: 12-19. PMID 9472656 DOI: 10.1046/J.1365-2249.1998.00465.X  0.449
1997 Nkengasong JN, Fransen K, Willems B, Karita E, Vingerhoets J, Kestens L, Colebunders R, Piot P, van der Groen G. Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O. Journal of Medical Virology. 51: 202-9. PMID 9139084 DOI: 10.1002/(Sici)1096-9071(199703)51:3<202::Aid-Jmv10>3.0.Co;2-M  0.413
1997 Vingerhoets J, Kestens L, Penne G, De Vuyst H, Vandenbruaene M, Pelgrom Y, Bosmans E, de Boer M, Kasran A, Azuma M, Colebunders R, Ceuppens JL, Vanham G. CD8+ cells and not CD4+ T cells are hyporesponsive to CD28- and CD40L-mediated activation in HIV-infected subjects. Clinical and Experimental Immunology. 107: 440-7. PMID 9067514 DOI: 10.1046/J.1365-2249.1997.D01-964.X  0.431
1997 Vingerhoets J, Bisalinkumi E, Penne G, Bosmans E, Colebunders B, Kestens L, Vanham G. Reduced sensitivity of CD8+ but not CD4+ T cells from HIV-infected patients to IL-2, IL-7 and IL-12: Implications for activation and apoptosis Immunology Letters. 56: 134-135. DOI: 10.1016/S0165-2478(97)85537-X  0.382
1997 Vingerhoets J, Kestens L, Penne G, Colebunders R, Dohlsten M, Vanham G. Intrinsic defect to superantigen stimulation in CD4 and CD8 T cells from HIV-infected patients: Role of co-stimulatory molecules and cytokines Immunology Letters. 56: 30-31. DOI: 10.1016/S0165-2478(97)85116-4  0.47
1996 Strauss K, Hannet I, Engels S, Shiba A, Ward DM, Ullery S, Jinguji MG, Valinsky J, Barnett D, Orfao A, Kestens L. Performance evaluation of the FACSCount System: a dedicated system for clinical cellular analysis. Cytometry. 26: 52-9. PMID 8809481 DOI: 10.1002/(Sici)1097-0320(19960315)26:1<52::Aid-Cyto8>3.0.Co;2-I  0.343
1996 Vanham G, Edmonds K, Qing L, Hom D, Toossi Z, Jones B, Daley CL, Huebner B, Kestens L, Gigase P, Ellner JJ. Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clinical and Experimental Immunology. 103: 30-4. PMID 8565282 DOI: 10.1046/J.1365-2249.1996.907600.X  0.514
1995 De Meester IA, Kestens LL, Vanham GL, Vanhoof GC, Vingerhoets JH, Gigase PL, Scharpé SL. Costimulation of CD4+ and CD8+ T cells through CD26: the ADA-binding epitope is not essential for complete signaling. Journal of Leukocyte Biology. 58: 325-30. PMID 7665988 DOI: 10.1002/Jlb.58.3.325  0.359
1995 Peeters M, Janssens W, Haesevelde MV, Fransen K, Willems B, Heyndrickx L, Kestens L, Piot P, Groen GVD, Heeney J. Virologic and serologic characteristics of a natural chimpanzee lentivirus infection. Virology. 211: 312-315. PMID 7645227 DOI: 10.1006/Viro.1995.1407  0.39
1995 Van Laer L, Vingerhoets J, Vanham G, Kestens L, Bwayo J, Otido J, Piot P, Roggen E. In vitro stimulation of peripheral blood mononuclear cells (PBMC) from HIV- and HIV+ chancroid patients by Haemophilus ducreyi antigens. Clinical and Experimental Immunology. 102: 243-50. PMID 7586673 DOI: 10.1111/J.1365-2249.1995.Tb03772.X  0.452
1995 Kestens L, Vingerhoets J, Peeters M, Vanham G, Vereecken C, Penne G, Niphuis H, van Eerd P, van der Groen G, Gigase P. Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection. The Journal of Infectious Diseases. 172: 957-63. PMID 7561216 DOI: 10.1093/Infdis/172.4.957  0.46
1995 Vingerhoets JH, Vanham GL, Kestens LL, Penne GG, Colebunders RL, Vandenbruaene MJ, Goeman J, Gigase PL, De Boer M, Ceuppens JL. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects. Clinical and Experimental Immunology. 100: 425-33. PMID 7539725 DOI: 10.1111/j.1365-2249.1995.tb03717.x  0.331
1994 Vanham G, Kestens L, Vingerhoets J, Penne G, Colebunders R, Vandenbruaene M, Goeman J, Ceuppens JL, Sugamura K, Gigase P. The interleukin-2 receptor subunit expression and function on peripheral blood lymphocytes from HIV-infected and control persons. Clinical Immunology and Immunopathology. 71: 60-8. PMID 8137559 DOI: 10.1006/Clin.1994.1052  0.476
1994 Adjorlolo-Johnson G, De Cock KM, Ekpini E, Vetter KM, Sibailly T, Brattegaard K, Yavo D, Doorly R, Whitaker JP, Kestens L. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. Jama. 272: 462-6. PMID 8040982 DOI: 10.1001/Jama.1994.03520060062033  0.434
1994 Vingerhoets J, Vanham G, Kestens L, Penne G, Leroux-Roels G, Gigase P. Deficient T-cell responses in non-responders to hepatitis B vaccination: absence of TH1 cytokine production. Immunology Letters. 39: 163-8. PMID 8013962 DOI: 10.1016/0165-2478(94)90102-3  0.314
1994 Locher C, Vanham G, Kestens L, Kruger M, Ceuppens JL, Vingerhoets J. Expression patterns of Fcγ receptors, HLA-DR and selected adhesion molecules on monocytes from normal and HIV-infected individuals Clinical and Experimental Immunology. 98: 115-122. PMID 7923868 DOI: 10.1111/J.1365-2249.1994.Tb06616.X  0.43
1994 Lucas SB, De Cock KM, Hounnou A, Peacock C, Diomande M, Hondé M, Beaumel A, Kestens L, Kadio A. Contribution of tuberculosis to slim disease in Africa. Bmj (Clinical Research Ed.). 308: 1531-3. PMID 7912597 DOI: 10.1136/Bmj.308.6943.1531  0.487
1994 Colebunders R, Sow S, Blot K, Vandenbruaene M, Heerackers Y, Kestens L, Van Ham G, Cornelissen W. HIV diagnosis delay in Antwerp, Belgium Journal of Epidemiology and Community Health. 48: 212. PMID 7910627 DOI: 10.1136/Jech.48.2.212  0.415
1994 Kestens L, Vanham G, Vereecken C, Vandenbruaene M, Vercauteren G, Colebunders RL, Gigase PL. Selective increase of activation antigens HLA-DR and CD38 on CD4+CD45RO+ T lymphocytes during HIV-1 infection Clinical and Experimental Immunology. 95: 436-441. PMID 7907956 DOI: 10.1111/J.1365-2249.1994.Tb07015.X  0.483
1994 De Meester I, Vanham G, Kestens L, Vanhoof G, Bosmans E, Gigase P, Scharpé S. Binding of adenosine deaminase to the lymphocyte surface via CD26. European Journal of Immunology. 24: 566-70. PMID 7907293 DOI: 10.1002/Eji.1830240311  0.34
1993 Vanham GL, Kestens L, Van Hoof J, Penne G, Colebunders R, Goilav C, Vandenbruaene M, el Habib R, Gigase P. Immunological parameters during treatment with ditiocarb (Imuthiol). Aids (London, England). 7: 525-30. PMID 8389559 DOI: 10.1097/00002030-199304000-00012  0.468
1993 Colebunders R, Kintin D, Fleerackers Y, Demeulenaere T, Vandenbruaene M, Goeman J, Kestens L, Farber C, Soete F. Surveillance case definition for AIDS in resource-poor countries The Lancet. 342: 864-865. PMID 8104289 DOI: 10.1016/0140-6736(93)92723-7  0.483
1992 Vanham G, Kestens L, Penne G, Goilav C, Gigase P, Colebunders R, Vandenbruaene M, Goeman J, van der Groen G, Ceuppens JL. Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. Journal of Clinical Immunology. 11: 345-56. PMID 1761640 DOI: 10.1007/Bf00918800  0.516
1992 Kestens L, Vanham G, Gigase P, Young G, Hannet I, Vanlangendonck F, Hulstaert F, Bach BA. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection. Aids (London, England). 6: 793-7. PMID 1418775 DOI: 10.1097/00002030-199208000-00004  0.492
1992 Kestens L, Brattegaard K, Adjorlolo G, Ekpini E, Sibailly T, Diallo K, Gigase PL, Gayle H, De Cock KM. Immunological comparison of HIV-1-, HIV-2- and dually-reactive women delivering in Abidjan, Côte d'Ivoire. Aids (London, England). 6: 803-7. PMID 1329848 DOI: 10.1097/00002030-199208000-00006  0.448
1991 Kestens L, Hoofd G, Gigase PL, Deleys R, van der Groen G. HIV antigen detection in circulating immune complexes Journal of Virological Methods. 31: 67-76. PMID 2016394 DOI: 10.1016/0166-0934(91)90145-P  0.418
1990 Vanham G, Kestens L, Gigase P, Colebunders R, Vandenbruaene M, Brijs L, Ceuppens JL. Evidence for circulating activated cytotoxic T cells in HIV-infected subjects before the onset of opportunistic infections Clinical and Experimental Immunology. 82: 3-9. PMID 2208794 DOI: 10.1111/J.1365-2249.1990.Tb05395.X  0.495
1987 Ambinder RF, Newman C, Hayward GS, Biggar R, Melbye M, Kestens L, Van Marck E, Plot P, Gigase P, Wright PB, Quinn TC. Lack of Association of Cytomegalovirus with Endemic African Kaposi’s Sarcoma Journal of Infectious Diseases. 156: 193-197. PMID 3036956 DOI: 10.1093/Infdis/156.1.193  0.313
1985 Kestens L, Melbye M, Biggar RJ, Stevens WJ, Piot P, De Muynck A, Taelman H, De Feyter M, Paluku L, Gigase PL. Endemic African Kaposi's sarcoma is not associated with immunodeficiency. International Journal of Cancer. 36: 49-54. PMID 4018905 DOI: 10.1002/Ijc.2910360109  0.317
Show low-probability matches.